According to a report by McKinsey, factors like COVID-19 pandemic, inflation, geopolitics, new therapeutic modalities, and new ways of working make it vital for pharmacos to carefully reconsider their long-term choices in sourcing, manufacturing, and supply chain.
The same report also states that the pharma industry is facing a multitude of challenging trends such as high inflation and an increase in complexity and risk.
The pharmaceutical industry is one of the most regulated, complex, and competitive sectors in the world. It faces many challenges such as: